Edition:
United States

Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

6.13USD
4:00pm EDT
Change (% chg)

$0.04 (+0.66%)
Prev Close
$6.09
Open
$6.05
Day's High
$6.16
Day's Low
$5.78
Volume
25,878
Avg. Vol
99,038
52-wk High
$29.02
52-wk Low
$5.54

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.37 December 17 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 6 12.61 15.50 10.68 104.10
Quarter Ending Mar-19 4 23.15 44.10 15.00 --
Year Ending Dec-18 6 56.46 61.57 53.00 119.14
Year Ending Dec-19 6 68.55 86.25 43.00 68.75
Earnings (per share)
Quarter Ending Dec-18 6 -0.37 -0.27 -0.48 2.50
Quarter Ending Mar-19 4 -0.08 0.63 -0.33 --
Year Ending Dec-18 6 -1.26 -1.08 -1.44 -0.19
Year Ending Dec-19 6 -1.20 -0.25 -2.33 -2.62

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 12.91 19.38 6.47 50.13
Quarter Ending Mar-18 15.11 11.19 3.92 25.92
Quarter Ending Dec-17 16.21 12.99 3.22 19.85
Quarter Ending Sep-17 20.00 18.08 1.92 9.62
Quarter Ending Jun-17 19.94 20.29 0.35 1.76

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 12.61 12.61 12.61 12.61 104.10
Quarter Ending Mar-19 23.15 23.15 24.87 24.87 --
Year Ending Dec-18 56.46 56.46 56.46 56.46 119.14
Year Ending Dec-19 68.55 68.55 68.55 68.55 68.75

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings